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ABSTRACT
TSC1-TSC2 complex has emerged as a signal interaction core
within the cell. This complex integrates both nutrient and growth
factor signaling and is a critical negative regulator of mTORC1.
mTORC1 signaling leads to increased protein biosynthesis, which is
essential for cell proliferation. Other cellular events such as endo-
plasmic reticulum stress and authophagy are intimately linked with
TSC/mTORC1 pathway and play an important role in pancreatic β
cell death or survival. We found that either insulin, glucose inde-
pendent signaling or the energetic status of the cell are able to mod-
ulate TSC2 phosphorylation in pancreatic β cell lines. To show the
central role of TSC2 for these cells, we conducted siRNA-mediated
TSC2 silencing. Downregulation of TSC2 leads to an increase in
mTORC1/p70S6K signaling, this produces resistance to insulin ac-
tion. However, specific expression of insulin receptor isoform A re-
stored insulin signalling under these conditions. Moreover, we have
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explored other processes related to the TSC/mTORC1 pathway and
their effect on cell death or survival.
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RESUMEN
Papel del complejo TSC1-TSC2 en la señalización de la célula β
pancreática: prolifreración, muerte y supervivencia celular
El complejo TSC1-TSC2 ha emergido como un núcleo de integración
de la señalización de factores de crecimiento y del estado energético ce-
lular. Este complejo funciona como un regulador negativo de la activi-
dad de mTORC1. La señalización a través de mTORC1 dirige la síntesis
proteica, esencial para la proliferación celular. Otros procesos como el
estrés de retículo y la autofagia están íntimamente ligados a la ruta
TSC/mTORC1 y juegan un importante papel en la muerte o superviven-
cia de las células β pancreáticas. Encontramos que tanto la insulina,
como la acción independiente de la glucosa o el estatus energético ce-
lular modulan la fosforilación de TSC2 en líneas celulares β pancreáti-
cas. Para demostrar el papel central de TSC2 en la regulación de estas
células, hemos silenciado su expresión mediante transfección con ARNi.
Una menor expresión de TSC2 lleva a un aumento de la señalización de
mTORC1/p70S6K, lo cual produjo un estado de resistencia a la acción
de la insulina. Sin embargo, la expresión selectiva de la isoforma A del
receptor de insulina consigue salvar esta resistencia. Por otro lado, he-
mos explorado otros procesos modulados por la ruta como la autofagia
o el estrés de retículo, y su efecto en la supervivencia o muerte celular.
Palabras Clave: TSC2; mTORC1; célula beta; diabetes; insulina.
1.  INTRODUCTION
β cells are a highly specialized cell type for the production and se-
cretion of insulin, which is required for maintaining metabolic home-
ostasis. Through a tight regulation of insulin levels, β cells are the en-
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ergetic sensor for the metabolic control of the whole organism. Insulin
demand is increased under different physiological and pathological
conditions, such as pregnancy, obesity or aging (1, 2). These various
conditions enforce the β cell mass to adapt to higher insulin synthe-
sis and secretion requirements. Thus, β cell plasticity can be accom-
plished by an increase in β cell mass, which is the net result of both
cell hyperplasia and cell hypertrophy (3). The failure of these com-
pensatory mechanisms results in an insulin deficiency that leads to
hyperglycemia and clinical manifestations of type 2 diabetes (3).
Autocrine insulin signaling on β cells has shown to be essential in
these compensatory mechanisms (4). On this regard, downstream ef-
fectors of insulin signaling such as Akt and the 70-kDa ribosomal pro-
tein S6 kinase (p70S6K) have proven to be positive key regulators of
β cell mass (5, 6).
Glucose is the main effector of insulin secretion in β cells, but it
also plays a role in β cell proliferation. Mice haploinsufficient for glu-
cokinase are unable to increase β cell mass in response to high-fat
diet (7). Furthermore, glucose has been found to stimulate ERK 1/2
activation (8, 9). This activation is independent of insulin signaling as
seen in IR -/- β cells (10). Glucose directly increases ATP/AMP ratio
inhibiting AMP-activated protein kinase (AMPK) activity.
The TSC1-TSC2 complex is located in the crossroad of this sig-
naling network, integrating different signals to determine the cellu-
lar fate through regulation of protein synthesis, cell size and prolif-
eration (11). The GTPase-activating protein (GAP) activity of TSC2
towards Ras homolog enriched in brain (Rheb) negatively regulates
mTORC1 signaling. Akt and ERK directly phosphorylates TSC2 lead-
ing to an increase in mTORC1 signaling (12, 13). In contrast, AMPK
activation has been found to phosphorylate TSC2 and stabilize the
TSC1-TSC2 complex, leading to a diminished mTORC1 activity un-
der low energetic states (14). TSC/mTORC1/p70S6K signaling path-
way is tightly regulated. Although a diminished mTORC1/p70S6K
activity can lead to a decrease in β cell mass and diabetes, its hy-
peractivity induces an insulin resistance state by a negative feedback
loop on IRS-1/2 (15). As the key regulator of protein synthesis,
mTORC1 hyperactivity can also lead to endoplasmic reticulum as-
sociated stress (ER stress) (16). β cell ER has a high capacity of pro-
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tein synthesis and folding, which in turn makes them extremely
prone to misfolded protein accumulation (17). Moreover, mTORC1
regulates the autophagic activity of the cell, which has proved to be
essential for β cell homeostasis (18).
Just recently, animal models have shown the key role of TSC1-
TSC2 complex in pancreatic β cells. Specific disruption of the com-
plex in β cells by either TSC1 (19), TSC2 deletion (20, 21) or Rheb
overexpression (22), results in hyperinsulinemia and improved glu-
cose tolerance mainly due to an increase in β cell size.
Alternative splicing of the IR (insulin receptor) results in two
isoforms, one encoding the 36 nucleotide exon 11 (IRB) and the
other one without it (IRA) (23). The relative expression of the two
isoforms varies among different tissues (24), and may play a role
in different pathological conditions such as cancer or insulin resist-
ance (25). We have recently observed an increase of IRA in pancre-
atic islets from inducible-liver IR knock-out (iLIRKO) mice show-
ing compensatory β cell hyperplasia in response to hepatic insulin
resistance (26).
Here, we report a differential regulation of TSC2 phosphorylation
and mTORC1 signaling by insulin, glucose, or energetic status in pan-
creatic β cell lines. Also are described its consequences on prolifera-
tion, and the involvement of autophagy or ER stress in β cell death
or survival.
2.  MATERIALS AND METHODS
2.1.  Antibodies and reagents
All antibodies were from Cell Signaling Biotechnology unless stat-
ed otherwise. Exceptions were IR-β (Santa Cruz), TSC1 (Bethyl
Laboratories), P-mTOR Ser2448 (Biosource), β-actin (Sigma), anti-
mono and poly-ubiquitinated protein conjugates FK2 mAb (Enzo Life
Sciences). Antibody against P-TSC2 Ser664 used for Western-blot was
a generous gift from P.P. Pandolfi (Beth Israel Deaconess Medical
Center, Boston, MA). Chemicals were from Calbiochem (U0126, wort-
mannin and rapamycin) or Sigma-Aldrich.
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2.2.  Origin of pancreatic β cell lines and cell culture
IR +/+ and IR -/- pancreatic β cells from IR loxP mice were gener-
ated as described before (10). From IR -/- cells, expression of a single
IR isoform was reconstituted by retroviral infection, and the differen-
tial mRNA splicing was assessed by RT-PCR as previously described
(27). TSC2 -/- and TSC2 +/+ MEFs were provided by D. J. Kwiatkowsky
(Dana-Farber Cancer Institute, Boston, MA).
2.3.  Cell signalling, Western-blotting and immunofluorescence
assays
For cell signaling experiments, cells were serum and glucose
starved for 3 h in DMEM containing 0.2 mM glucose and 0.5% bovine
serum albumin (BSA), and subsequently stimulated with insulin 10
nM or glucose 5 mM for 5 or 15 min respectively. Inhibitors were
added 30 min prior to stimulus. Cells were washed and lysed for pro-
tein extraction, protein concentration was determined and samples
were subjected to SDS-PAGE for Western-blot according to standard
procedures (10). Immunofluorescence, cell cycle and violet crystal as-
says assays were carried as decribed previously (10).
2.4.  siRNA trasnfection
siRNA against the expression of mouse TSC2 was designed and
chemically synthesized by Bionova Científica SL. For siRNA transfec-
tion, cells were electroporated using Nucleofector II and Cell Line Kit
T (Amaxa) following the instructions from the manufacturer. A pool
of three different siRNA (2 μg) was added to the transfection reagent
per 2x106 cells. After transfection, cells were seeded and protein ex-
pression was checked after 24-48 h
2.5.  λ-Phosphatase treatment
100 μg of total lysates were mixed in λ-Phosphatase Buffer (50 mM
Tris-HCl pH7.5, 0.1 mM Na2EDTA, 5 mM dithiothreitol, 0.01% BRIJ
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35, 2 mM MnCl2) with 400 U of λ-Phosphatase (Sigma), and then the
mixture was incubated for 1 h at 30 °C.
2.6.  Statistics
Statistically significant differences between mean values were de-
termined using paired Student t-test for paired comparisons. One-way
ANOVA and Tukey tests were used for multiple comparisons.
Differences were considered statistically significant at P < 0.05.
3.  RESULTS
3.1.  Characterization of pancreatic β cell lines
Different β cell lines were generated and used in our study (IR +/+,
IR -/-, Rec A and Rec B). From an IR -/- β cell line generated in a pre-
vious work (10), Rec A and Rec B cell lines were reconstituted by
retrovirus-mediated transfection with a human IRA or IRB encoding
plasmids. IR levels were measured by Western-blotting (Figure 1A),
and RT-PCR of IR exon 11 mRNA determined the specific expression
of both isoforms (Figure 1B).
Figure 1.  Specific recostitution of IR isoforms. A) IR expression by Western-blot
in the different pancreatic β cell lines: IR +/+, IR -/-, and reconstituted cell lines sta-
bly expressing IRA (Rec A), or IRB (Rec B). A densitometric analysis of the IR levels
is shown, data are presented as means ± S.E.M. (n = 5). B) Total RNA was isolated,
and IR exon 11 expression was checked by RT-PCR.
3.2.  Insulin stimulates TSC/mTORC1 signaling pathway through
PI3K/Akt in pancreatic β cells
To assess the signaling pathway specificity of insulin or glucose-
mediated TSC2 phosphorylation, we used selective inhibitors of the
class I PI3K (wortmannin 40 nM), and MEK 1/2 (U0126 5 μM). Use
of wortmannin blocked insulin-stimulated Akt Ser473 phosphorylation
and subsequently TSC2 Ser939 and Thr1462 phosphorylation and
mTORC1 activity. Inhibition of MEK/ERK pathway did not affect ei-
ther Akt or TSC2 phosphorylation levels. Surprisingly, although both
reconstituted cell lines express similar levels of IR (Figure 1A), wort-
mannin 40 nM only partially impaired Akt/TSC2 phosphorylation in
IRA expressing β cell line. However, this phosphorylation was totally
blunted in IR +/+ or IRB expressing β cells (Figure 2). Time-course
stimulation also revealed a more sustained phosphorylation of
Akt/TSC2 in Rec A cells versus Rec B cells (data not shown). In IR -
/- cells, glucose did not stimulate either Akt or TSC2 phosphorylation
in these residues. However, glucose stimulated p70S6K Thr389 phos-
phorylation (Figure 2).
3.3.  Glucose activates TSC/mTORC1 signaling via ERK 1/2 
independently from insulin signaling in pancreatic 
β cells
To test whether glucose by itself was capable to stimulate TSC2
Ser664 phosphorylation in pancreatic β cells, we submitted IR -/- β cells
to 5 mM glucose stimulation. We found a glucose-mediated activation
of TSC2 Ser664 phosphorylation by Western-blot analysis (Figure 3A).
This phosphorylation was completely blunted by the addition of
U0126. TSC2 Ser664 phosphorylation has been described as a marker
of hyperactivation of MEK/ERK signaling in tuberous sclerosis, breast
and colon human cancer (28).
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3.4.  Energetic status-dependent modulation of mTORC1
AMPK is the energetic sensor of the cell and it is activated by a
rise in AMP/ATP ratio (29). Thus, AMPK-Thr172 phosphorylation is de-
creased by glucose and increased by 2 deoxylucose (2-DG) in a dose-
dependent manner as well as by 4 mM AICAR in IR +/+ β cells.
Activation of AMPK by 2-DG or AICAR addition to the culture medi-
um inhibited mTOR and p70S6K phosphorylation. Conversely, inac-
Figure 2. Insulin and glucose action on the PI3K/TSC/mTORC1 pathway. Cells
were stimulated with insulin 10 nM for 5 min (IR +/+, Rec A and Rec B), or glucose
5 mM (IR -/-) for 15 min. Specific inhibitors were added 30 min prior to stimulation
(wortmannin 40 nM, U0126 5 μM). Protein extracts were collected and submitted to
Western-blot with the use of specific antibodies. Blots are representative of three in-
dependent experiments. Quantification of the most significative points is shown. Data
are presented as means ± S.E.M. *P < 0.05 compared to control points.
tivation of AMPK by glucose resulted in an enhancement of mTOR
and p70S6K phosphorylation (Figure 3B). Thus, activation of AMPK
can directly regulate mTORC1 inhibition. In a similar manner, AMPK
activation caused Raptor-Ser792 phosphorylation, which has been de-
scribed as an additional mechanism to downregulate mTORC1 signal-
ing, independently from TSC1-TSC2 complex (30). The role of the TSC
complex in energy sensing response was observed, as the phosphory-
lation of TSC2 by AMPK activation causes a mobility shift of the TSC2
protein in poliacrylamide gel electrophoresis, which is reverted by λ-
phosphatase treatment of the samples (Figure 3C).
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Figure 3.  Glucose and energy dependent modulation of TSC2 and mTORC1.
A) IR -/- were stimulated with glucose 5 mM for 15 min. U0126 5 μM was added 30
min prior to the stimulus. Protein extracts were submitted to immunoprecipitation
with anti-TSC2 antibody, and blotted with a phosphospecific anti TSC2-Ser664 anti-
body. Total lysates were used for Western-blot against P-ERK 1/2. B) IR +/+ cells were
stimulated with glucose 5 mM, 2-DG (2-5 mM) or AICAR 4 mM. C) IR +/+ cells were
stimulated or not with 2-DG 5 mM for 15 minutes, protein extracts were collected
and part of the samples were treated with λ-phosphatase. Samples were subjected to
SDS-PAGE and incubated with specific antibodies. Blots are representative of at least
three independent experiments.
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3.5.  Effect of TSC2 interference on pancreatic β cell signaling
To assess the importance of TSC complex in the integration of β
cell signaling, we targeted the expression of TSC2 with siRNA. A sim-
ilar rate of TSC2 knockdown was achieved in all the cell lines, close
to 70% of protein expression interference (Figure 4B). TSC2 knock-
down induced p70S6K basal phosphorylation in all cell lines studied
(Figure 4A). TSC2 interference generated insulin resistance, decreas-
ing Akt and p70S6K phosphorylation in response to insulin in IR +/+
(Figure 4, A and C). However, this insulin resistance effect was de-
pendent on the IR isoform expression. Thus, Rec A, but not Rec B
cells overcome insulin resistance on Akt Ser473 and p70S6K phospho-
rylation (Figure 4, A, C and D). In addition, TSC2 interference gener-
ated insulin resistance, decreasing ERK 1/2 phosphorylation in IR +/+,
Rec A, or Rec B cell lines (Figure 4A). The insulin resistance induced
by TSC inactivation in IR +/+ or Rec B cells was blunted by rapamycin
treatment, indicating a requirement for mTORC1 signaling. In con-
trast, the effect observed on ERK 1/2 was rapamycin-independent in
all cell lines studied (Figure 4A). In IR -/- cells, TSC2 interference im-
paired glucose mediated ERK 1/2 phosphorylation. However, glucose
induced p70S6K signaling regardless of the presence of the MEK 1/2
inhibitor U0126 through ERK 1/2 independent pathway (Figure 4A,
upper right panel). To further investigate the differences between IRA
or IRB expression on insulin resistance, we stimulated cells with in-
sulin 10 nM for 15 minutes, and observed a different modulation of
IRS-1 Ser307 phosphorylation. This phosphorylation is mediated by
p70S6K, as described before (15), reverted by rapamycin, and upreg-
ulated in Rec B cells compared with Rec A or IR +/+ cells (Figure 5).
3.6.  Role of the TSC2/mTORC1 pathway in the proliferation of
pancreatic β cells bearing IRA or IRB isoforms
To assess the role played by mTORC1 in the proliferation rate of β
cell lines studied, we submitted those cells to 10% FBS in the presence
or absence of rapamycin 40 nM (Figure 6). The rate of proliferation, as
estimated by cell counting, increased by 8-fold in IR +/+ or in Rec B
and by 4-fold in IR -/- cells (Figure 6, A and B). In addition, Rec A cells
showed a much higher rate of proliferation under the same experimen-
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Figure 4. Effect of TSC2 interference on insulin and glucose signaling. A) 24
h after siRNA transfection cells were stimulated with insulin 10 nM for 5 min (IR
+/+, Rec A and Rec B), or glucose 5 mM for 15 min (in IR -/- cells, right upper pan-
nel). Specific inhibitors were added 30 min before stimulation. Blots are representa-
tive of four independent experiments. B) Densitometric analysis showing the percent-
age of TSC2 deletion in TSC2-interfered cells compared to control cells. Results are
means ± S.E.M. of the level of interference reached. C) Fold-increase of p70S6K Thr389
phosphorylation after insulin or glucose stimulation in control and TSC2-interfered
cells. Results are means ± S.E.M. *P < 0.05 compared to control cells. The differences
between the ratios of fold-stimulation between control and TSC2-interfered cells were
calculated and significant differences are indicated #P < 0.05. D) Fold-increase of Akt
Ser473 phosphorylation after insulin or glucose stimulation in control and TSC2-in-
terfered cells. Results are means ± S.E.M. *P < 0.05 compared to control cells.
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tal conditions (10-fold increase). Addition of rapamycin lowered the
proliferation rate in all the cell lines studied, but this effect was of dif-
ferent magnitude. In Rec A cells the effect of rapamycin on prolifera-
tion was a 4-fold decrease while in Rec B cells only a 2-fold decrease
was observed (Figure 6, A and B). Flow cytometry assays showed a ten-
dency in cell size increase after TSC2 interference, although it was not
statistically significant (data not shown). In addition, TSC2 interference
increased the number of cells in S/G2-M phase in all cell lines studied
(Figure 6C). These data were confirmed by crystal violet assays (Figure
6D). Rapamycin treatment reverted the increased proliferation mediat-
ed by TSC2 knockdown in all cell lines studied (Figure 6, A, B and C).
3.7.  Critical roles of autophagy and ER-stress in β cell death or
survival
ER-stress and autophagy are closely related to TSC2/mTORC1 sig-
naling. TSC deficiency is known to lead to ER-stress (16), and mTORC1
blocking with rapamycin is a common way for inducing autophagy in
vitro (31). Both processes are also interplaying, as autophagy has a role
Figure 5.  Feedback loop on IRS-1 Ser307 is differentially activated depending
on IR isoform expression. Cells were glucose and serum deprived for 3 h, and then
were stimulated with insulin 10 nM for 15 min. Rapamycin 40 nM was added 30 min-
utes before stimulation. Blots are representative of three independent experiments.
Results are means ± S.E.M. *P < 0.05 compared to IR +/+ cells.
in misfolded protein clearance (31). β cells turned out to be more sen-
sible to apoptotic death mediated by chemical ER-stressors when com-
pared to fibroblasts (Figure 7A). Immunofluorescence assays showed
that both basal and rapamycin-induced autophagy is sensibly higher
in β cells than the observed in fibroblasts, observed as the number of
LC3B puncta on cells (Figure 7C). Even more shocking are the differ-
ences between both cell types when stained with FK2 mAb against
ubiquitin-protein conjugates, which showed higher levels of protein ag-
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Figure 6.  Effect of mTORC1 inhibition or overactivation on β cell prolifera-
tion. A) IR +/+ and IR -/- cells were counted and seeded at the same density, and
grown in glucose 1 g/L 10% FBS-DMEM. At 24 and 48 h, cells were counted. B) Same
experiment for Rec A and Rec B cells. Results are means ± S.E.M. *P < 0.05 com-
pared to control points. C) Transfected and control cells were grown in glucose 1 g/L
10% FBS-DMEM. DNA content was analyzed by flow cytometry. The bars represent
the percentual change of cells in S/G2-M phase compared to controls for each cell
line. D) Cells were seeded at the same density. After 24 and 48 h violet crystal stain
was measured as described. The differences between absorbances in 24 and 48 h, in
control or TSC2 downregulated cells, are represented. Results are means ± S.E.M. *P
< 0.05 compared to controls for each cell line.
ALBERTO BARTOLOMÉ Y COLS. AN. R. ACAD. NAC. FARM.
370
gregates in β cells. Interestingly, mTORC1 modulation rendered differ-
ent outcomes in the accumulation of these conjugates. Rapamycin-me-
diated blocking of mTORC1 diminished the accumulation observed in
β cells. On the other hand, TSC2 interference and the consequent
mTORC1 hyperactivation did not further increased staining in β cells.
In contrast, TSC2 -/- MEFs showed higher staining when compared
with TSC2 +/+ MEFs (Figure 7B). Chemical inhibition of autophagy
enhances ER-stress, or nutrient starvation mediated cell death in β cells
(Figures 7, D and E).
Figure 7.  ER-stress and autophagy interplay, effect on β cell death or survival.
A) Cell survival after 24h treatment with MG132 0,5 μM; Thaps: Thapsigargin 0,1 μM;
or DTT: dithiothreitol 5 mM, measured by violet crystal assay. B) Immunofluoresecence
against ubiquitin-protein conjugates with FK2 mAb antibody (green), nuclei are conun-
tersestained with DAPI (blue). Rapamycin 40 nM treatment for 24 h. TSC2 was inter-
fered with siRNA for 24 h in β cells, TSC2 -/- MEFs were used. C) Immunofluorescence
against LC3B (green), puncta is indicative of lipidated LC3B accumulation in au-
tophagosomes, while cytoplasmic staining is indicative of no autophagic activity.
Rapamycin 40 nM was used for 24 h. D) Pancreatic β-cell survival after 24 h treatment
with a lower concentration of MG132 (0,1 μM), and or CQ; chloroquine 25 μM by vi-
olet crystal assay. E) β-cell survival after 48 h of glucose deprivation, or 2-DG 5 mM;
and or CQ 25 μM by violet crystal assay. Results are means ± S.E.M. significative dif-
ferences are indicated *P < 0.05.
4.  DISCUSSION
Recent animal models have pointed out the relevance of TSC1-
TSC2 complex acting as a repressor of mTORC1 for the control of β
cell mass. Thus, β cell specific knockout models of TSC1 or TSC2, or
Rheb overexpression results in an augmented β cell mass, mainly be-
cause of a huge cell hypertrophy (19-22). The importance of mTORC1
functioning in human β cells is also patent; progressive impairment
in β cell function was observed in patients who received β cell trans-
plantation and were treated with rapamycin as an immunosuppres-
sant (32). We previously demonstrated that insulin or glucose inde-
pendently induced proliferation signaling in pancreatic β cells of fetal
origin (10). Now, we address the important issue of the integration of
both independent signaling in the regulation of β cells proliferation.
Insulin stimulation mediates TSC2 phosphorylation in a PI3K/Akt-
dependent manner leading to diminished TSC2 activity towards Rheb,
and subsequently producing downstream mTORC1 activation (12).
More importantly, insulin stimulates Akt/TSC2/p70S6K and
MEK/ERKs pathways in either IRA or IRB expressing cell lines. These
results contrast with previous data showing specific signaling for each
of the IR isoforms (33, 34). However, insulin induced a more sustained
signaling in Rec A as compared with Rec B cell lines. In fact, wort-
mannin did not completely block either Akt or TSC2 phosphorylation
in Rec A as compared with Rec B β cells. These results suggest that
IRA confers a stronger proliferation capability as compared with IRB
in response to insulin, as we recently published in iLIRKO primary
islets (26).
Glucose is an essential proliferation and survival factor for pan-
creatic β cells (7, 10). Glucose stimulation in vitro is able to induce
ERK 1/2 phosphorylation, independently from insulin secretion in β
cells (10). ERK 2 directly phosphorylates TSC Ser664 in HEK293T cells
(13), and was increased in several human tumours leading to an up-
regulation of mTORC1 signaling (28). Neither TSC2 Ser939 nor Thr1462
phosphorylation was observed upon glucose stimulation in β cells.
However, TSC2 Ser664 was stimulated by glucose in a MEK/ERK-de-
pendent manner. Glucose can also exert its effects on mTORC1 sig-
naling by modulation of ATP levels and therefore by AMPK inhibi-
tion. AMPK, on one hand, directly stabilizes TSC1-TSC2 complex (14)
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and on the other, modulates an essential component of mTORC1,
Raptor (30). AMPK activation implicates a strong inhibition of
mTORC1, which can be reverted by glucose addition. We have proven
that AMPK activation can induce Raptor Ser792 phosphorylation in
pancreatic β cells, contributing to energy deprivation-mediated im-
pairment in mTORC1/p70S6K signaling.
TSC2 interference causes an increase in p70S6K activity and insulin
resistance in IR +/+ or Rec B β cells on Akt stimulation. Lately, some
animal and cellular models have shown the importance of the regula-
tion of mTORC1 in the physiology of β cells. Although mTORC1/p70S6K
hyperactivity can lead to IRS-mediated insulin resistance, trials failed
to globally diminish it by blocking mTORC1 with the use of rapamycin,
because a functional mTORC1 is required for β cell adaptation (35).
The inhibition of mTORC1 with rapamycin reverted the insulin resist-
ance on Akt stimulation in our cell lines. More importantly, IRA recon-
stituted cells overcome the insulin resistance seen above showing in-
sulin-mediated Akt stimulation even though TSC2 knockdown. Our data
suggest that the inhibition of the upstream insulin signaling mediated
by p70S6K overactivation feedback mechanism, may be differentially
modulated in IRA or IRB expressing cells. Phosphorylation of IRS-1
Ser307 is considered a marker of insulin resistance (36). The negative
loop concerning IRS-1 Ser307 phosphorylation was upregulated in Rec
B cells as compared to Rec A cells in response to insulin. This might
explain the differences observed on Akt Ser473 phosphorylation between
Rec A and Rec B cells when we interfered TSC2 expression.
In our β cell lines, we found an increase of proliferation in all cell
lines when TSC2 was interfered. This increase was dependent on
mTORC1 activity as rapamycin addition blocked the stimulatory ef-
fect of TSC2 interference on cell proliferation. Our results point out
the higher mitogenic effect of IRA versus IRB isoform in the regula-
tion of β cell proliferation.
Other processes related with TSC2/mTORC1 are also critical for β
cell death or survival. We found β cells to be more susceptive to cell
death in response to ER-stressors compared with fibroblasts. Both au-
tophagy and ER-stress is basally increased in β cells, observed as the
increased number of puncta of LC3B and ubiquitin-protein conjuga-
tes, respectively. This may be explained as β cells have a highly deve-
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loped ER specialized for the production of insulin, and any stress such
as in vitro culture makes them prone to misfolded protein accumula-
tion, and extremely sensible to ER-stress mediated cell death. We be-
lieve that the basal autophagic level observed in β cells may be a di-
rect consequence of the higher misfolded protein accumulation.
Finally, we found autophagy to be protective under certain conditions
such as glucose starvation or ER-stress.
In conclusion, here we described the relevance of TSC1-TSC2 com-
plex in the integration of insulin and glucose independent signaling in
pancreatic β cell proliferation (Figure 8). This complex participates co-
ordinating multiple signals from either energetic or hormonal status,
determining the functioning of protein synthesis through mTORC1.
This route has been described as critical for β cell mass maintenance,
and may play a very important role in the β cell mass hyperplasia as-
sociated with insulin resistance states. Also, the role of autophagy and
Figure 8.  Insulin and glucose signaling toward TSC complex and mTORC1.
Integration of insulin or glucose-independent signaling by TSC1-TSC2 complex con-
verging on mTORC1/p70S6K proliferation pathway in pancreatic β-cells. Also is de-
picted the effect on autophagy and ER-stress.
ER-stress may be involved in β cell death or survival. At this stage, the
relative expression of IRA versus IRB within the β cells may play an
essential role in the regulation of pancreatic β cell proliferation. A bet-
ter knowledge of the molecular mechanisms involved in β cell plastic-
ity is needed to understand its role in type 2 diabetes progression.
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